Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

    Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

    Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

    We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

    1. Home

    2. Perspectives

    3. Changing Paradigms in Breast Cancer Screening

    Changing Paradigms in Breast Cancer Screening

    5min
    Martin Lindner
    Published on October 16, 2019

    Increasing detection performance with tomosynthesis

    Detecting breast cancer earlier could lead to reducing breast cancer mortality.

    Speeding up breast MRI for efficient use

    Adaptation of an abbreviated MRI protocol significantly increases patient throughput and may allow MRI to serve as a stand-alone breast cancer screening tool.

    Mootz et al, Eur J Breast Health, 2019

    Towards risk-stratified screening strategies

    One-size-fits-all approaches are easier to implement, but there is a growing intent to do better.

    Mireille Broeders, Radboud University Medical Center, the Netherlands
    By Martin Lindner

    Martin Lindneris is an award-winning science writer based in Berlin, Germany. After completing his medical studies and a doctoral thesis in the history of medicine, he went into journalism. His articles have appeared in many major German and Swiss newspapers and magazines.

    1. Lauby-Secretan B, Scoccianti C, Loomis D et al (2015) Breast-cancer screening – viewpoint of the IARC Working Group. N Engl J Med 372:2353-8

    2. Zackrisson S, Lång K, Rosso A et al (2018) One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study. Lancet Oncol 19: 1493–503

    3. Wernli KJ, DeMartini WB, Ichikawa L et al (2014) Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med 174:125-32

    4. Kuhl CK, Schrading S, Strobel K et al (2014) Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. J Clin Oncol 32:2304-10

    5. Harvey SC, Di Carlo PA, Lee B et al (2016) An Abbreviated Protocol for High-Risk Screening Breast MRI Saves Time and Resources. J Am Coll Radiol 13:374-80

    6. Deike-Hofmann K, Koenig F, Paech D et al (2019) Abbreviated MRI Protocols in Breast Cancer Diagnostics. J Magn Reson Imaging 49:647-658

    7. Mootz AR, Madhuranthakam AJ, Doğan B (2019) Changing Paradigms in Breast Cancer Screening: Abbreviated Breast MRI. Eur J Breast Health 15:1-6

    8. Louro J, Posso M, Hilton Boon M et al (2019) A systematic review and quality assessment of individualised breast cancer risk prediction models. Br J Cancer. doi: 10.1038/s41416-019-0476-8 [Epub ahead of print]

    9. van Veen EM, Brentnall AR, Byers H et al (2018) Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction. JAMA Oncol 4:476-482

    10. My Personal Breast Screening (MyPeBS): Randomized Comparison Of Risk-Stratified versus Standard Breast Cancer Screening In European Women Aged 40-70. www.brumammo.be/documents/docs/bmm-my-pebs-clinical-trial-protocol.pdf (last accessed 4 June 2019)

    11. Rainey L, Jervaeus A, Donnelly LS et al (2019) Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study. Psychooncology 28:1056-1062

    1. The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.